Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 9, 2011, Pages 556-563

  Pou, Jordi ^a   Martínez González, José ^b   Rebollo, Alba ^a   Rodríguez, Cristina ^b   Rodríguez Calvo, Ricardo ^b   Martín Fuentes, Paula ^c   Cenarro, Ana ^c   Civeira, Fernando ^c   Laguna, Juan C ^a,d   Alegret, Marta ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institut Català de Ciències Cardiovasculars   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Atherosclerosis; Interleukin 1 receptor; Lipoprotein; Monocyte; THP 1 macrophage

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; INTERLEUKIN 1 RECEPTOR TYPE II; LIPOPOLYSACCHARIDE; LIPOPROTEIN; MESSENGER RNA; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ATHEROSCLEROSIS; CELL LINE; HUMANS; INTERLEUKIN-1; MACROPHAGES; MALE; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, INTERLEUKIN-1 TYPE II; SIGNAL TRANSDUCTION;

EID: 79960562367     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.05.014     Document Type: Article

References (38)

1. J.H. von der Thusen, J. Kuiper, T.J. van Berkel, and E.A. Biessen Interleukins in atherosclerosis: molecular pathways and therapeutic potential Pharmacol. Rev. 55 2003 133 166 (Pubitemid 36268401)
2. R. Elhage, A. Maret, M.T. Pieraggi, J.C. Thiers, J.F. Arnal, and F. Bayard Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice Circulation 97 1998 242 244 (Pubitemid 28067308)
3. C.A. Dinarello Immunological and inflammatory functions of the interleukin-1 family Annu. Rev. Immunol. 27 2009 519 550
4. D. Neumann, C. Kollewe, M.U. Martin, and D. Boraschi The membrane form of the type II IL-1 receptor accounts for inhibitory function J. Immunol. 165 2000 3350 3357
5. G. Llaverias, J. Pou, E. Ros, D. Zambon, M. Cofan, A. Sanchez, M. Vazquez-Carrera, R.M. Sanchez, J.C. Laguna, and M. Alegret Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment Pharmacogenomics 9 2008 1035 1054
6. R. Zimmermann, P. Sartipy, R. Winkler, R. Zechner, E. Hurt-Camejo, and G.M. Kostner Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins Biochim. Biophys. Acta 1484 2000 316 324 (Pubitemid 30175980)
7. G. Llaverias, D. Lacasa, M. Vinals, M. Vazquez-Carrera, R.M. Sanchez, J.C. Laguna, and M. Alegret Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin Biochem. Pharmacol. 68 2004 155 163 (Pubitemid 38746551)
8. G. Larigauderie, C. Cuaz-Perolin, A.B. Younes, C. Furman, C. Lasselin, C. Copin, M. Jaye, J.C. Fruchart, and M. Rouis Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of beta-oxidation FEBS J. 273 2006 3498 3510 (Pubitemid 44086950)
9. X. Wang, Y. Zheng, Y. Xu, J. Ben, S. Gao, X. Zhu, Y. Zhuang, S. Yue, H. Bai, Y. Chen, L. Jiang, Y. Ji, Y. Xu, L. Fan, J. Sha, Z. He, and Q. Chen A novel peptide binding to the cytoplasmic domain of class A scavenger receptor reduces lipid uptake in THP-1 macrophages Biochim. Biophys. Acta 1791 2009 76 83
10. J.A. Gomez-Gerique, J.A. Gutierrez-Fuentes, M.T. Montoya, A. Porres, A. Rueda, A. Avellaneda, and M.A. Rubio Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group Med. Clin. (Barc.) 113 1999 730 735
11. G. Llaverias, M. Jove, M. Vazquez-Carrera, R.M. Sanchez, C. Diaz, G. Hernandez, J.C. Laguna, and M. Alegret Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages Eur. J. Pharmacol. 451 2002 11 17 (Pubitemid 35246360)
12. G. Llaverias, D. Lacasa, M. Vazquez-Carrera, R.M. Sanchez, J.C. Laguna, and M. Alegret Cholesterol regulation of genes involved in sterol trafficking in human THP-1 macrophages Mol. Cell. Biochem. 273 2005 185 191 (Pubitemid 40766800)
13. J. Persson, J. Nilsson, and M.W. Lindholm Interleukin-1 beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells BMC Immunol. 9 2008 70 81
14. M. Garcia-Ramirez, J. Martinez-Gonzalez, J.O. Juan-Babot, C. Rodriguez, and L. Badimon Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth Arterioscler. Thromb. Vasc. Biol. 25 2005 2398 2403 (Pubitemid 41552661)
15. C.Q. Duong, S.M. Bared, A. bu-Khader, C. Buechler, A. Schmitz, and G. Schmitz Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages Biochim. Biophys. Acta 1682 2004 112 119 (Pubitemid 38670541)
16. A. Akoum, C. Lawson, C. Herrmann-Lavoie, and R. Maheux Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis Hum. Reprod. 22 2007 1464 1473 (Pubitemid 47062820)
17. C. Bellehumeur, J. Blanchet, J.Y. Fontaine, N. Bourcier, and A. Akoum Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms Hum. Reprod. 24 2009 2193 2204
18. L. Kritharides, A. Christian, G. Stoudt, D. Morel, and G.H. Rothblat Cholesterol metabolism and efflux in human THP-1 macrophages Arterioscler. Thromb. Vasc. Biol. 18 1998 1589 1599 (Pubitemid 28465411)
19. D. Milosavljevic, A. Kontush, S. Griglio, N.G. Le, J. Thillet, and M.J. Chapman VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass Biochim. Biophys. Acta 1631 2003 51 60 (Pubitemid 36165103)
20. V. Saraswathi, and A.H. Hasty The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages J. Lipid Res. 47 2006 1406 1415 (Pubitemid 44079894)
21. L. Lipskaia, M.L. Pourci, C. Delomenie, L. Combettes, D. Goudouneche, J.L. Paul, T. Capiod, and A.M. Lompre Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation Circ. Res. 92 2003 1115 1122 (Pubitemid 36665857)
22. S. Kosaka, S. Takahashi, K. Masamura, H. Kanehara, J. Sakai, G. Tohda, E. Okada, K. Oida, T. Iwasaki, H. Hattori, T. Kodama, T. Yamamoto, and I. Miyamori Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages Circulation 103 2001 1142 1147 (Pubitemid 32200190)
23. W.F. Fearon, and D.T. Fearon Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist Circulation 117 2008 2577 2579
24. J. Ma, A.A. Dempsey, D. Stamatiou, K.W. Marshall, and C.C. Liew Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects Atherosclerosis 191 2007 63 72 (Pubitemid 46227430)
25. J. Persson, E. Degerman, J. Nilsson, and M.W. Lindholm Perilipin and adipophilin expression in lipid loaded macrophages Biochem. Biophys. Res. Commun. 363 2007 1020 1026 (Pubitemid 47559155)
26. A.M. Palmer, E. Nova, E. Anil, K. Jackson, P. Bateman, E. Wolstencroft, C.M. Williams, and P. Yaqoob Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages Atherosclerosis 180 2005 233 244 (Pubitemid 41072892)
27. J. Pou, A. Rebollo, and M. Alegret The monocyte/macrophage as a therapeutic target in atherosclerosis: focus on cholesterol homeostasis and inflammation M. Vázquez-Carrera, New Emerging Pharmacological Targets in Metabolic Diseases 2007 Transworld Research Network Kerala 27 50
28. R.W. St Clair, and Sulistiyani Effect of 17 beta-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture Arterioscler. Thromb. Vasc. Biol. 17 1997 1691 1700 (Pubitemid 27423989)
29. Y.C. Hung, M.Y. Hong, and G.S. Huang Cholesterol loading augments oxidative stress in macrophages FEBS Lett. 580 2006 849 861 (Pubitemid 43152305)
30. M. Napolitano, M. Avella, N.T. Goode, K.M. Botham, and E. Bravo Cholesterol esterification in human monocyte-derived macrophages is inhibited by protein kinase C with dual roles for mitogen activated protein kinases Cell Biol. Int. 28 2004 717 725 (Pubitemid 39423681)
31. S. Saccani, N. Polentarutti, G. Penton-Rol, J.E. Sims, and A. Mantovani Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo Cytokine 10 1998 773 780 (Pubitemid 28495228)
32. G. Penton-Rol, S. Orlando, N. Polentarutti, S. Bernasconi, M. Muzio, M. Introna, and A. Mantovani Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts J. Immunol. 162 1999 2931 2938 (Pubitemid 29309321)
33. J.G. Giri, J. Wells, S.K. Dower, C.E. McCall, R.N. Guzman, J. Slack, T.A. Bird, K. Shanebeck, K.H. Grabstein, J.E. Sims, and M.R. Alderson Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses J. Immunol. 153 1994 5802 5809 (Pubitemid 24377716)
34. C. Kollewe, A.C. Mackensen, D. Neumann, J. Knop, P. Cao, S. Li, H. Wesche, and M.U. Martin Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling J. Biol. Chem. 279 2004 5227 5236 (Pubitemid 38220541)
35. A. Lockett, M.G. Goebl, and M.A. Harrington Transient membrane recruitment of IRAK-1 in response to LPS and IL-1beta requires TNF R1 Am. J. Physiol Cell Physiol. 295 2008 C313 C323
36. A. Akoum, C. Jolicoeur, A. Kharfi, and M. Aube Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis Am. J. Pathol. 158 2001 481 489 (Pubitemid 32162166)
37. A. Kharfi, A. Boucher, and A. Akoum Abnormal interleukin-1 receptor type II gene expression in the endometrium of women with endometriosis Biol. Reprod. 66 2002 401 406 (Pubitemid 34101837)
38. S. Guay, and A. Akoum Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology Reproduction 134 2007 525 534 (Pubitemid 47386899)